4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-20-035506
Options or other derivatives
- Director acquired 28,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bruhn Suzanne Louise · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-08 | Grant or award : show line 1 in the form Director Stock Option (right to buy) | +28,100 | 28,100 | D |
Loading xslF345X03/doc4.xml…